Additionally, cryptotanshinone, a bioactive component from traditional Chinese medicine, inhibits BC cell proliferation, migration, and invasion via downregulation of PKM2 through the PKM2/β-catenin signaling pathway (124). Here, PKM is linked to breast cancer.